TY - JOUR
T1 - Retrospective screening of microarray data to identify candidate IFN-inducible genes in a HTLV-1 transformed model
AU - Refaat, Alaa
AU - Owis, Mohamed
AU - Abdelhamed, Sherif
AU - Saiki, Ikuo
AU - Sakurai, Hiroaki
N1 - Publisher Copyright:
© 2018, Spandidos Publications. All rights reserved.
PY - 2018/4
Y1 - 2018/4
N2 - HuT-102 cells are considered one of the most repre-sentable human T-lymphotropic virus 1 (HTLV-1)-infected cell lines for studying adult T-cell lymphoma (ATL). In our previous studies, genome-wide screening was performed using the GeneChip system with Human Genome Array U133 Plus 2.0 for transforming growth factor-β-activated kinase 1 (TAK1)-, interferon regulatory factor 3 (IRF3)- and IRF4-regulated genes to demonstrate the effects of interferon-inducible genes in HuT-102 cells. Our previous findings demonstrated that TAK1 induced interferon inducible genes via an IRF3-dependent pathway and that IRF4 has a counteracting effect. As our previous data was performed by manual selection of common interferon-related genes mentioned in the literature, there has been some obscure genes that have not been considered. In an attempt to maximize the outcome of those microarrays, the present study reanalyzed the data collected in previous studies through a set of computational rules implemented using ‘R’ software, to identify important candidate genes that have been missed in the previous two studies. The final list obtained consisted of ten genes that are highly recommend as potential candidate for therapies targeting the HTLV-1 infected cancer cells. Those genes are ATM, CFTR, MUC4, PARP14, QK1, UBR2, CLEC7A (Dectin-1), L3MBTL, SEC24D and TMEM140. Notably, PARP14 has gained increased attention as a promising target in cancer cells.
AB - HuT-102 cells are considered one of the most repre-sentable human T-lymphotropic virus 1 (HTLV-1)-infected cell lines for studying adult T-cell lymphoma (ATL). In our previous studies, genome-wide screening was performed using the GeneChip system with Human Genome Array U133 Plus 2.0 for transforming growth factor-β-activated kinase 1 (TAK1)-, interferon regulatory factor 3 (IRF3)- and IRF4-regulated genes to demonstrate the effects of interferon-inducible genes in HuT-102 cells. Our previous findings demonstrated that TAK1 induced interferon inducible genes via an IRF3-dependent pathway and that IRF4 has a counteracting effect. As our previous data was performed by manual selection of common interferon-related genes mentioned in the literature, there has been some obscure genes that have not been considered. In an attempt to maximize the outcome of those microarrays, the present study reanalyzed the data collected in previous studies through a set of computational rules implemented using ‘R’ software, to identify important candidate genes that have been missed in the previous two studies. The final list obtained consisted of ten genes that are highly recommend as potential candidate for therapies targeting the HTLV-1 infected cancer cells. Those genes are ATM, CFTR, MUC4, PARP14, QK1, UBR2, CLEC7A (Dectin-1), L3MBTL, SEC24D and TMEM140. Notably, PARP14 has gained increased attention as a promising target in cancer cells.
KW - Adult T-cell lymphoma
KW - Computational biology
KW - Human T-lymphotropic virus 1
KW - Interferon-inducible genes
KW - Microarray
UR - http://www.scopus.com/inward/record.url?scp=85042658258&partnerID=8YFLogxK
U2 - 10.3892/ol.2018.8014
DO - 10.3892/ol.2018.8014
M3 - 学術論文
C2 - 29616088
AN - SCOPUS:85042658258
SN - 1792-1074
VL - 15
SP - 4753
EP - 4758
JO - Oncology Letters
JF - Oncology Letters
IS - 4
ER -